We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
This study hypothesized that ENaC contributes to the increase in renalsodium reabsorption following a meal.
4
Context: A genetic variant in alpha-adducin has been associated with renalsodium reabsorption and salt-sensitive hypertension.
5
Thus, disruption of the D3 receptor increases renal renin production and produces renalsodium retention and renin-dependent hypertension.
6
Abnormalities in renalsodium reabsorption may be involved in the development and maintenance of experimental and clinical hypertension.
7
Sodium regulating hormones remained unaffected by desmopressin, indicating a possible direct effect of the agent on renalsodium handling.
8
The present study aimed to elucidate the role of Na, K-ATPase inhibitor in renalsodium metabolism in essential hypertension.
9
The onset of hypertension in spontaneously hypertensive rats (SHRs) is preceded by defects in renalsodium excretion.
10
Consequences of this neurohumoral activation with arterial uderfilling include renalsodium and water retention and an increase in peripheral vascular resistance.
11
However, the functional significance of ATRAP in renalsodium handling and blood pressure regulation under pathological stimuli is not fully resolved.
12
The impaired renalsodium handling in primary hypertension and salt sensitivity may be caused by aberrant counter-regulatory natriuretic and anti-natriuretic pathways.
13
Background: Nitric oxide (NO) is an important regulator of renalsodium transport and participates in the control of natriuresis and diuresis.
14
The aim of this study was to determine the effect of NO depletion on renalsodium handling in a model of diet-induced obesity hypertension.
15
To assess renalsodium handling under non-steady-state conditions, we infused 2 L normal saline intravenously over a 2-hour period.
16
Conclusions: These results demonstrated that distal tubule-dominant enhancement of ATRAP inhibits pathological renalsodium reabsorption and blood pressure elevation in response to HS loading.